<?xml version="1.0" encoding="UTF-8"?>
<p id="para40">No fully proven and specific antiviral treatment for the coronavirus exists. Guidance from China's National Health Commission suggests taking an anti-HIV drug combination of lopinavir and ritonavir and inhaling a dose of nebulised interferon Î± for the antiviral therapy.
 <xref rid="bib13" ref-type="bibr">
  <sup>13</sup>
 </xref> Many efforts, including several clinical trials, such as 
 <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04246242" id="interrefs20" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04246242</ext-link> and 
 <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04252664" id="interrefs30" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04252664</ext-link>, are in progress to screen existing antiviral drugs to identify those that could be specific and efficient against 2019-nCoV. Notably, the first reported use of remdesivir, in the first diagnosed patient with 2019-nCoV infection in the USA,
 <xref rid="bib14" ref-type="bibr">
  <sup>14</sup>
 </xref> has encouraged additional clinical study of this medication.
</p>
